Editas Medicine, Inc.
EDIT
$2.65
$0.000.00%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -108.95M | -160.06M | -199.84M | -236.86M | -251.23M |
| Total Depreciation and Amortization | 3.84M | 5.28M | 7.64M | 6.73M | 6.32M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.30M | 20.77M | 22.69M | 23.53M | 20.44M |
| Change in Net Operating Assets | -50.69M | -31.23M | -10.12M | 5.24M | 16.27M |
| Cash from Operations | -140.50M | -165.24M | -179.62M | -201.36M | -208.21M |
| Capital Expenditure | -585.00K | -607.00K | -1.09M | -3.58M | -7.07M |
| Sale of Property, Plant, and Equipment | 425.00K | 269.00K | 151.00K | 151.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 82.51M | 139.01M | 170.50M | 217.40M | 230.35M |
| Cash from Investing | 82.35M | 138.67M | 169.57M | 213.97M | 223.28M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 41.91M | 43.34M | 26.29M | 9.12M | 2.03M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -2.87M | 52.37M | 52.37M | 52.37M |
| Cash from Financing | 41.91M | 40.47M | 78.66M | 61.49M | 54.40M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.25M | 13.90M | 68.61M | 74.10M | 69.47M |